{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:09:37Z","timestamp":1783742977026,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.joms.2021.07.029","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:15:30Z","timestamp":1628396130000},"page":"2472-2481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience"],"prefix":"10.1016","volume":"79","author":[{"given":"Shuo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9866-8513","authenticated-orcid":false,"given":"Hongyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2021.07.029_bib0001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2021.07.029_bib0002","first-page":"2014","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"1938","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0003","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0004","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.joms.2008.12.003","article-title":"Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Freiberger","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00198-019-05199-w","article-title":"A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration","volume":"31","author":"Ohbayashi","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2021.07.029_bib0006","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcms.2020.02.017","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: a systematic review","volume":"48","author":"Vanpoecke","year":"2020","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0007","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2021.07.029_bib0008","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12992","article-title":"Surgical treatment of medication-related osteonecrosis of the upper jaw: case series","volume":"25","author":"Aljohani","year":"2019","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2021.07.029_bib0009","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.ijom.2020.05.011","article-title":"Combined reconstruction plate fixation and submandibular gland translocation for the management of medication-related osteonecrosis of the mandible","volume":"49","author":"Zhou","year":"2020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph17238801","article-title":"Surgical treatment of medication-related osteonecrosis of the jaw: a retrospective study","volume":"17","author":"Choi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.joms.2021.07.029_bib0011","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.joms.2021.07.029_bib0012","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bjoms.2017.06.014","article-title":"Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2","volume":"55","author":"Coropciuc","year":"2017","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0013","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcms.2016.08.001","article-title":"Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws","volume":"44","author":"Klingelhoffer","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0014","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.joms.2020.12.045","article-title":"Factors influencing severity of medication-related osteonecrosis of the jaw: a retrospective study","volume":"79","author":"Feng","year":"2021","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamaoncol.2020.6353","article-title":"Association of osteonecrosis of the jaw with zoledronic acid treatment for bone metastases in patients with cancer","volume":"7","author":"Van Poznak","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.joms.2021.07.029_bib0016","first-page":"e326","article-title":"Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab vs. zoledronic acid: a systematic review and meta-analysis","volume":"25","author":"Limones","year":"2020","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2021.07.029_bib0017","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.joms.2021.07.029_bib0018","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2021.07.029_bib0019","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.joms.2021.07.029_bib0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","article-title":"Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol","volume":"22","author":"Ramaglia","year":"2018","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.joms.2021.07.029_bib0021","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jcms.2018.05.003","article-title":"Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up","volume":"46","author":"Nisi","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0022","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bjoms.2016.06.015","article-title":"Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaws: a series of 120 patients","volume":"54","author":"Nisi","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0023","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: surgical or non-surgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2021.07.029_bib0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.oooo.2015.10.033","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III","volume":"121","author":"Bodem","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2021.07.029_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.102003","article-title":"Fluorescence-guided surgical management of medication-related osteonecrosis of the jaws","volume":"32","author":"Tomo","year":"2020","journal-title":"Photodiagn Photodyn Ther"},{"key":"10.1016\/j.joms.2021.07.029_bib0026","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","article-title":"Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series","volume":"46","author":"Aljohani","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0027","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jcms.2019.07.012","article-title":"Fluorescence-guided bone resection: a histological analysis in medication-related osteonecrosis of the jaw","volume":"47","author":"Wehrhan","year":"2019","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0028","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jcms.2015.12.017","article-title":"The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"44","author":"Mucke","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2021.07.029_bib0029","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcms.2018.03.005","article-title":"Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw\u2014a single center cohort study","volume":"46","author":"Ristow","year":"2018","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239121007515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239121007515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:04:12Z","timestamp":1759511052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239121007515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0278239121007515"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2021.07.029","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2021.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Association of Oral and Maxillofacial Surgeons.","name":"copyright","label":"Copyright"}]}}